JSH-23
SIGMA/J4455 - ≥98% (HPLC), solid
Synonym: 4-
CAS Number: 749886-87-1
Empirical Formula (Hill Notation): C16H20N2
Molecular Weight: 240.34
Linear Formula: C16H20N2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white to gray-pink |
| form | solid |
| InChI | 1S/C16H20N2/c1-13-9-10-16 |
| InChI key | YMFNPBSZFWXMAD-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | N(CCCc2ccccc2)c1c(cc(cc1) |
| solubility | DMSO: >10 mg/mL |
| storage condition | protect from light |
| storage temp. | −20°C |
| Application: | JSH-23 has been used as a nuclear factor κB (NF-κB) p65 inhibitor. |
| Biochem/physiol Actions: | JSH-23 is an inhibitor of NF-kB nuclear translocation. |
| Biochem/physiol Actions: | JSH-23 is an inhibitor of NF-kB nuclear translocation. It inhibits LPS and cytokine-induced nuclear translocation of the p65 subunit of NF-kB as analyzed by EMSA and western blot. The compound displays modest potency (IC50 7.1 uM in RAW 264.7), but has the unique property that it does not affect IkB degradation or recovery. The compound dose dependently inhibits LPS induced expression of cytokines, COX2 and iNOS, and presumably binds to, or interferes with the NLS of p65. |
| Other Notes: | Light and air sensitive. |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xn,N |
| Risk Statements | 22-41-50/53 |
| Safety Statements | 26-39-60-61 |
| RIDADR | UN 3077 9 / PGIII |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 51111800 |

